je.st
news
Tag: adults
Canada: Hundreds of young adults talk 'climate justice' at Dalhousie
2014-03-30 16:00:00| Climate Ark Climate Change & Global Warming Newsfeed
Chronicle Herald: There was a hint of emotion in the 23-year-olds voice as she described the future she imagines. It isnt pretty. Ocean acidification, rising sea levels and shifting agricultural tolerance mean that life as we now know it isnt guaranteed in the future, she said. Im fine now. Were comfortable now, but 15 years from now, 25 years from now, will we have food on the table? I dont know, said Chelsea Renee Fougere. The resident of Wilmot Station, near Greenwood, was one of about 500 young...
Tags: canada
talk
young
justice
UK: Adventurous adults boost lingerie market
2014-03-28 15:58:00| Daily apparel & textile news and comment - from just-style.com
The UK market for lingerie, corsetry and hosiery has shown consistent growth in value over the past five years, according to new research, as the adult population excels in a more sexually liberated mass consciousness.
Tags: market
adults
boost
lingerie
Half of US adults 40 to 75 eligible for statins
2014-03-19 22:54:09| Biotech - Topix.net
This 2011 photo provided by Watson Pharmaceuticals Inc. shows bottles of Atorvastatin Calcium tablets, a generic form of Lipitor which is sold under a deal with Pfizer.
Tags: for
half
adults
eligible
Half of US adults 40 to 75 eligible for statins
2014-03-19 22:54:08| Biotech - Topix.net
The sentencing hearing for an Army general who admitted to inappropriate relationships with three subordinates is expected to wrap up Wednesday after testimony by friends and colleagues who praised his leadership.
Tags: for
half
adults
eligible
New 96-Week ACTG Study Results Presented at CROI 2014; First Large Study Comparing ISENTRESS (raltegravir) Regimen to Two Protease Inhibitor Regimens in Previously Untreated Adults with HIV-1
2014-03-05 18:15:00| Merck.com - Product News
Dateline City: BOSTON BOSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, said today that in a new 96-week, open-label AIDS Clinical Trials Group (ACTG) study designed to compare three different NNRTI-sparing HIV regimens in treatment-nave patients one containing Mercks twice-daily ISENTRESS (raltegravir) and two containing different once-daily ritonavir-boosted protease inhibitors, atazanavir and darunavir -- all three regimens achieved high and equivalent levels of efficacy, as measured by time to virologic failure (V Language: English Contact: MerckMedia:Caroline Lappetito, 267-305-7639orSarra Herzog, 201-669-6570orInvestor:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
results
large
study
Sites : [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] next »